Alteration of blood brain barrier permeability by T-2 toxin: Role of MMP-9 and inflammatory cytokines

Toxicology

Volumn 280, Issue 1-2, 2011, Pages 44-52

  Ravindran, Jayaraj ^a   Agrawal, Mona ^a   Gupta, Nimesh ^a   Lakshmana Rao, P V ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Blood brain barrier permeability; Inflammatory cytokines; MMP; Reactive oxygen species,; T 2 toxin

Indexed keywords

EVANS BLUE; GELATINASE A; GELATINASE B; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; T 2 TOXIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN LEVEL; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; GENE EXPRESSION; INFLAMMATION; LIPID PEROXIDATION; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN; TISSUE; ZYMOGRAPHY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CYTOKINES; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; MICE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PERMEABILITY; SPLEEN; T-2 TOXIN;

FUSARIUM; FUSARIUM EQUISETI; FUSARIUM POAE;

EID: 78650518373     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.11.006     Document Type: Article

References (49)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Agarwal R., Shukla G.S. Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem. Res. 1999, 24:1507-1514.
3. Agrawal S., Anderson P., Durbeej M., van Rooijen N., Ivars F., Opdenakker G., Sorokin L.M. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1007-1019.
4. Ahmadi K., Riazipour M. Effects of T-2 toxin on cytokine production by mice peritoneal macrophages and lymph node T-cells. Iran J. Immunol. 2008, 5:177-180.
5. Albarenque S.M., Doi K. T-2 toxin-induced apoptosis in rat keratinocyte primary cultures. Exp. Mol. Pathol. 2005, 78:144-149.
6. Albarenque S.M., Suzuki K., Nakayama H., Doi K. Kinetics of cytokines mRnas expression in the dorsal skin of WBN/ILA-Ht rats following topical application of T-2 toxin. Exp. Toxicol. Pathol. 2001, 53:271-274.
7. Bennett J.W., Klich M. Mycotoxins. Clin. Microbiol. Rev. 2003, 16:497-516.
8. Bergmann F., Yagen B., Jarvis B.B. The toxicity of macrocyclic trichothecenes administered directly into the rat brain. Toxicon 1992, 30:1291-1294.
9. Boje K.M. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res. 1996, 720:75-83.
10. Bouaziz C., Sharaf El Dein O., El Golli E., Abid-Essefi S., Brenner C., Lemaire C., Bacha H. Different apoptotic pathways induced by zearalenone T-2 toxin and ochratoxin A in human hepatoma cells. Toxicology 2008, 254:19-28.
11. Bunner D.L., Morris E.R. Alteration of multiple cell membrane functions in L-6 myoblasts by T-2 toxin: an important mechanism of action. Toxicol. Appl. Pharmacol. 1988, 92:113-121.
12. Cavan K.R., MacDonald E.J., Smith T.K. Potential for dietary amino acid precursors of neurotransmitters to overcome neurochemical changes in acute T-2 toxicosis in rats. J. Nutr. 1988, 118:901-907.
13. Chaudhari M., Jayaraj R., Bhaskar A.S., Lakshmana Rao P.V. Oxidative stress induction by T-2 toxin causes DNA damage and triggers apoptosis via caspase pathway in human cervical cancer cells. Toxicology 2009, 262:153-161.
14. Chaudhari M., Jayaraj R., Santhosh S.R., Lakshmana Rao P.V. Oxidative damage and gene expression profile of antioxidant enzymes after T-2 toxin exposure in mice. J. Biochem. Mol. Toxicol. 2009, 23:212-221.
15. Chi M.S., El-Halawani M.E., Waibel P.E., Mirocha C.J. Effects of T-2 toxin on brain catecholamines and selected blood components in growing chickens. Poultry Sci. 1981, 60:137-141.
16. Doring A., Wild M., Vestweber D., Deutsch U., Engelhardt B. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J. Immunol. 2007, 179:8470-8479.
17. Eugenin E.A., Berman J.W. Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods 2003, 29:351-361.
18. Ferrari C.C., Depino A.M., Prada F., Muraro N., Campbell S., Podhajcer O., Perry V.H., Anthony D.C., Pitossi F.J. Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am. J. Pathol. 2004, 165:1827-1837.
19. Fujimura M., Morita-Fujimura Y., Noshita N., Sugawara T., Kawase M., Chan P.H. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J. Neurosci. 2000, 20:2817-2824.
20. Gupta N., Lomash V., Lakshmana Rao P.V. Expression profile of Japanese encephalitis virus induced neuroinflammation and its implication in disease severity. J. Clin. Virol. 2010, 49:4-10.
21. Haorah J., Knipe B., Leibhart J., Ghorpade A., Persidsky Y. Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction. J. Leukoc. Biol. 2005, 78:1223-1232.
22. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
23. Iwahashi Y., Kitagawa E., Iwahashi H. Analysis of mechanisms of T-2 toxin toxicity using yeast DNA microarrays. Int. J. Mol. Sci. 2008, 9:2585-2600.
24. Kamada H., Yu F., Nito C., Chan P.H. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 2007, 38:1044-1049.
25. Kim S.R., Bae Y.H., Bae S.K., Choi K.S., Yoon K.H., Koo T.H., Jang H.O., Yun I., Kim K.W., Kwon Y.G., Yoo M.A., Bae M.K. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim. Biophys. Acta 2008, 1783:886-895.
26. Li M., Cuff C.F., Pestka J.J. T-2 toxin impairment of enteric reovirus clearance in the mouse associated with suppressed immunoglobulin and IFN-gamma responses. Toxicol. Appl. Pharmacol. 2006, 214:318-325.
27. Mirocha C.J., Pawlosky R.A., Chatterjee K., Watson S., Hayes W. Analysis for Fusarium toxins in various samples implicated in biological warfare in Southeast Asia. J. Assoc. Off. Anal. Chem. 1983, 66:1485-1499.
28. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
29. Ohkawa H., Ohishi N., Yagi K. Reaction of linoleic acid hydroperoxide with thiobarbituric acid. J. Lipid Res. 1978, 19:1053-1057.
30. Pinsky D.J., Cai B., Yang X., Rodriguez C., Sciacca R.R., Cannon P.J. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J. Clin. Invest. 1995, 95:677-685.
31. Pun P.B., Lu J., Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic. Res. 2009, 43:348-364.
32. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro Implications for atherosclerotic plaque stability. J. Clin. Invest. 1996, 98:2572-2579.
33. Reijerkerk A., Kooij G., van der Pol S.M., Khazen S., Dijkstra C.D., de Vries H.E. Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J. 2006, 20:2550-2552.
34. Rosen R.T., Rosen J.D. Presence of four Fusarium mycotoxins and synthetic material in 'yellow rain'. Evidence for the use of chemical weapons in Laos. Biomed. Mass Spectrom. 1982, 9:443-450.
35. Rosenberg G.A., Estrada E.Y., Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998, 29:2189-2195.
36. Sirkka U., Nieminen S.A., Ylitalo P. Acute neurobehavioural toxicity of trichothecene T-2 toxin in the rat. Pharmacol. Toxicol. 1992, 70:111-114.
37. Smith T.K., McMillan E.G., Castillo J.B. Effect of feeding blends of Fusarium mycotoxin-contaminated grains containing deoxynivalenol and fusaric acid on growth and feed consumption of immature swine. J. Anim. Sci. 1997, 75:2184-2191.
38. Tellmann G., Olivier G. Light cycler 480 Real-Time PCR System: innovative solutions for relative quantification. Biochemica 2006, 16-18.
39. Ueno Y. Toxicological features of T-2 toxin and related trichothecenes. Fundam. Appl. Toxicol. 1984, 4:S124-132.
40. Van der Goes A., Wouters D., Van Der Pol S.M., Huizinga R., Ronken E., Adamson P., Greenwood J., Dijkstra C.D., De Vries H.E. Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J. 2001, 15:1852-1854.
41. Wang J., Fitzpatrick D.W., Wilson J.R. Effect of dietary T-2 toxin on biogenic monoamines in discrete areas of the rat brain. Food Chem. Toxicol. 1993, 31:191-197.
42. Wang J., Fitzpatrick D.W., Wilson J.R. Effects of the trichothecene mycotoxin T-2 toxin on neurotransmitters and metabolites in discrete areas of the rat brain. Food Chem. Toxicol. 1998, 36:947-953.
43. Wannemacher R.W.B.D., Neufeld H.A. Toxicity of Trichothecenes and other related Mycotoxins in Laboratory Animals 1991, CRC Press.
44. Watson S.A., Mirocha C.J., Hayes A.W. Analysis for trichothecenes in samples from Southeast Asia associated with "Yellow Rain" Fundam. Appl. Toxicol. 1984, 4:700-717.
45. Weekley L.B., O'Rear C.E., Kimbrough T.D., Llewellyn G.C. Acute and chronic effects of the trichothecene mycotoxin T-2 on rat brain regional concentrations of serotonin, tryptophan, and tyrosine. Vet. Hum. Toxicol. 1989, 31:221-224.
46. Williams P.P. Effects of T-2 mycotoxin on gastrointestinal tissues: a review of in vivo and in vitro models. Arch. Environ. Contam. Toxicol. 1989, 18:374-387.
47. Yarom R., Yagen B. T-2 toxin effect on the ultrastructure of myocardial microvasculature. Br. J. Exp. Pathol. 1986, 67:55-63.
48. Yong V.W., Krekoski C.A., Forsyth P.A., Bell R., Edwards D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998, 21:75-80.
49. Yu F., Kamada H., Niizuma K., Endo H., Chan P.H. Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury. J. Neurotrauma 2008, 25:184-195.